Background: Hepatitis B virus (HBV) is one of the most widespread viruses worldwide and a
major cause of hepatitis, cirrhosis, and hepatocellular carcinoma. Previous studies have …

To evaluate of hepatitis serology and reactivation frequency in patients with rheumatic
disease receiving biologic agents. Our study included patients with inflammatory rheumatic …

Up to now, it has not been clear whether occult hepatitis B virus (HBV) infection (OBI) can be
treated with antiviral therapy whether OBI can develop drug resistance gene mutation or not …

Patients with rheumatic diseases infected with hepatitis B virus (HBV) are difficult to manage
not only due to the presence of risk factors for the development and rapid progression of …

Аннотация Пациенты с ревматическими заболеваниями, инфицированные вирусом
гепатита В (hepatitis B virus–HBV), трудны для курации вследствие не только наличия …

With the spread of coronavirus disease 2019 (COVID-19) worldwide, extrapulmonary
lesions, including liver dysfunction, have attracted growing attention. The mechanisms …

Background Occult hepatitis B virus infection (OBI) is a challenging entity. Due to the
increase in invasive procedures, blood transfusions, and difficulties in diagnosing OBI …

Amaç: İmmünsupresif tedavi altındaki yüksek riskli hastalarda hepatit B reaktivasyonu
antiviral profilaksi ile önlenebilir. Antiviral seçiminde entekavir (ETC) veya tenofovir …

abstract Background: Occult hepatitis B virus infection (OBI) is a challenging entity. Due to
the increase in invasive procedures, blood transfusions, and difficulties in diagnosing OBI …

Objective: B-cell depleting treatments are associated with potential risks of viral infections.
Hepatitis B virus (HBV) infection is the most common chronic viral infection and it is …